Bravera Wealth »

Bristol Myers Squibb shares owned by Bravera Wealth

Quarter-by-quarter ownership of Bristol Myers Squibb (BMY) shares owned by Bravera Wealth from 13F filings

Historical chart of Bravera Wealth investment in Bristol Myers Squibb

Tip: Access up to 7 years of quarterly data

All positions including Bristol Myers Squibb held by Bravera Wealth consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bristol Myers Squibb by Bravera Wealth

Quarter filed Position value Share count Share price at filing
2026-03-31 $111k 1.8k 60.65
2025-12-31 $98k 1.8k 53.94

More positions owned by Bravera Wealth

Vanguard 500 Index ETF S&p 500 Etf Shs (VOO)
Schwab U.S. Large-Cap Growth ETF Us Lcap Gr Etf (SCHG)
Vanguard Value Index ETF Value Etf (VTV)
Fidelity Enhanced International ETF Enhanced Intl (FENI)
Fidelity SMID Multifactor ETF Sml Mid Mltfct (FSMD)
First Trust SMID Cap Rising Dividend Achievers ETF Smid Risng Etf (SDVY)
Avantis U.S. Small Cap Value ETF Us Sml Cp Valu (AVUV)
Microsoft Corporation (MSFT)
First Trust Rising Dividend Achievers ETF Risng Divd Achiv (RDVY)
Schwab Fundamental U.S. Large Company ETF Fundamental Us L (FNDX)
Capital Group Dividend Value ETF Shs Creation Uni (CGDV)
Vanguard Dividend Appreciation ETF Div App Etf (VIG)
Vanguard Developed Markets Index FTSE ETF Van Ftse Dev Mkt (VEA)
Global X Adaptive U.S. Factor ETF Adaptive Us (AUSF)
SPDR S&P Dividend ETF State Street Spd (SDY)

View all positions for Bravera Wealth

Top funds holding Bristol Myers Squibb

Vanguard Group
BlackRock
State Street Corporation
Charles Schwab Investment Management
Geode Capital Management
Norges Bank Investment Management
Ameriprise Financial
AQR Capital Management
PRIMECAP Management Company
Northern Trust
Bank of New York Mellon
Ubs Global Asset Management Americas
Capital Research and Management Company - Division 3
Independent Franchise Partners
Goldman Sachs Group

View all funds holding Bristol Myers Squibb